Diagnoptics News

What's new?

Read all news items about the AGE Reader and Diagnoptics.

Review about AGE Reader in assessing CV risk and risk of diabetes

Groningen, the Netherlands – September 5, 2014.

An excellent review paper has been published in European Endocrinology this week. The authors reviewed all available clinical data on the AGE Reader and concluded that the non-invasive AGE Reader measurement shows a good predictive value (better than HbA1c) for the development of diabetic complications, microvascular and macrovascular disease, cardiovascular and overall mortality.

Besides reviewing the available clinical data the authors also give a comprehensive overview of the theoretical background on AGEs and measuring AGEs

The full-text version of this review paper can be downloaded free of charge HERE


Official reprints of this review are available free of charge at our booth on the upcoming EASD congress in Vienna (September 15-19).

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The 'AGE Reader mu' is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.